|
|
Article: VERONA PHARMA PLC - Clinical Trial Update.
- Article from:
- PR Newswire UK Disclose
- Article date:
- May 20, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
20 May 2009
Verona Pharma plc
("Verona Pharma" or the "Company")
First two stages of RPL554 Phase I/IIa Clinical Trial Yields Positive Results
Approval to proceed to final stage of trial
Verona Pharma, the AIM-quoted drug discovery company, is pleased to announce
that its asthma and allergic rhinitis (hay fever) treatment, RPL554, has
successfully completed the first two stages of its Phase I/IIa clinical trial
and received approval to proceed to the final stage of the trial. RPL554 is a
novel inhaled treatment for asthma and hay fever that does not involve
traditional steroids or beta ...